Posted by Michael Wonder on 23 Apr 2024
ICER and NEWDIGS release white paper analysing the challenges and potential policy options for paying for gene therapies
23 April 2024 - Paper outlines policy reforms and market actions to support innovation and access while managing uncertainty, affordability, and equity concerns; developed as part of ICER’s Policy Leadership Forum with input from diverse stakeholders,
The ICER and NEWDIGS at Tufts Medical Center have collaborated to publish a new white paper today that provides clear policy and market solutions to help manage the challenges of paying for gene therapies.
